Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $350.44K in the twelve months ending September 30, 2025, down -51.59% year-over-year. In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth.

• Revenue (ttm): 350.44K
• Revenue Growth: -51.59%
• P/S Ratio: 70.04
• Revenue / Employee: 58.41K
• Employees: 6
• Market Cap: 24.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	617.14K	59.43K	10.66%
Dec 31, 2023	557.71K	-431.33K	-43.61%
Dec 31, 2022	989.04K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-